 |
Cis-diamminedichloroplatinum (II) polyethylene glycol-polyglutamate (cis platinum PEG-pGlu) polymeric micelles |
|---|---|
| Trade Name | |
| Orphan Indication | Biliary tract carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 2017-07-27 00:00:00 |
| Sponsor | NanoCarrier Co., Ltd.;144-15 Chuno Gaiku, 226-39 Wakashiba;Kashiwa |
